NCT00223223View on ClinicalTrials.gov

Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Memory Loss Associated With Corticosteroid UseManic State Associated With Corticosteroid Use
Interventions
DRUG

Levetiracetam, Keppra

Trial Locations (1)

75235

The University of Texas Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER